As a result of the newly developed guidelines, laboratories were obligated to develop both diagnostic and carrier screening mutation panels that either were identical to or overlapped with respect to ...
Purpose: To validate a novel BeadChip assay system for cystic fibrosis (CF) mutation testing using the panel of 25 ACMG recommended mutations and D1152H. Methods: DNA from 519 individuals originally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback